INO: Inovio Pharmaceuticals, Inc. Stock

by  •  • Comments Off on INO: Inovio Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 65.83
Enterprise Value ($M) 0.02
Book Value ($M) 68.50
Book Value / Share 1.87
Price / Book 0.96
NCAV ($M) 53.14
NCAV / Share 1.45
Price / NCAV 1.24

Profitability (mra)
Return on Invested Capital (ROIC) -1.33
Return on Assets (ROA) -0.83
Return on Equity (ROE) -1.14

Liquidity (mrq)
Quick Ratio 2.77
Current Ratio 2.77

Balance Sheet (mrq) ($M)
Current Assets 97.83
Assets 113.20
Liabilities 44.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.22
Operating Income -112.40
Net Income -107.25
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -104.08
Cash from Investing 104.07
Cash from Financing 51.48

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-30 13G Vanguard Group Inc 5.53 21.23
04-17 13G/A BlackRock, Inc. 6.30 21.48
02-10 13G Highbridge Capital Management Llc 9.20
12-23 13G Stonepine Capital Management, LLC 5.20
2024-04-26 13G Deep Track Capital, LP 9.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 170,692 379,264 45.01
2025-05-08 70,285 372,331 18.88
2025-05-07 132,357 386,662 34.23
2025-05-06 259,256 532,562 48.68
2025-05-05 68,968 200,134 34.46

(click for more detail)

Similar Companies
INKT – MiNK Therapeutics, Inc. INM – InMed Pharmaceuticals Inc.
INMB – INmune Bio, Inc. INTS – Intensity Therapeutics, Inc.
IPA – ImmunoPrecise Antibodies Ltd.


Financial data and stock pages provided by
Fintel.io